Kim A, Ko H
Diabetes Metab Syndr Obes. 2018; 11:149-157.
PMID: 29719415
PMC: 5922244.
DOI: 10.2147/DMSO.S163062.
Hernandez-Rodas M, Valenzuela R, Videla L
Int J Mol Sci. 2015; 16(10):25168-98.
PMID: 26512643
PMC: 4632797.
DOI: 10.3390/ijms161025168.
Eslamparast T, Eghtesad S, Hekmatdoost A, Poustchi H
Middle East J Dig Dis. 2014; 5(3):129-36.
PMID: 24829682
PMC: 3990183.
Du J, Ma Y, Yu C, Li Y
World J Gastroenterol. 2014; 20(2):569-77.
PMID: 24574727
PMC: 3923033.
DOI: 10.3748/wjg.v20.i2.569.
Sung Y, Gwak G, Choi M, Koh K, Paik S, Yoo B
Gut Liver. 2012; 6(4):520-3.
PMID: 23170161
PMC: 3493737.
DOI: 10.5009/gnl.2012.6.4.520.
Gut microbiota and inflammation.
Hakansson A, Molin G
Nutrients. 2012; 3(6):637-82.
PMID: 22254115
PMC: 3257638.
DOI: 10.3390/nu3060637.
Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model.
Xu R, Wan Y, Fang Q, Lu W, Cai W
J Clin Biochem Nutr. 2012; 50(1):72-7.
PMID: 22247604
PMC: 3246186.
DOI: 10.3164/jcbn.11-38.
Non-alcoholic fatty liver disease: is iron relevant?.
OBrien J, Powell L
Hepatol Int. 2011; 6(1):332-41.
PMID: 22020821
DOI: 10.1007/s12072-011-9304-9.
Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.
Zein C, Yerian L, Gogate P, Lopez R, Kirwan J, Feldstein A
Hepatology. 2011; 54(5):1610-9.
PMID: 21748765
PMC: 3205292.
DOI: 10.1002/hep.24544.
Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.
Abu Shanab A, Scully P, Crosbie O, Buckley M, OMahony L, Shanahan F
Dig Dis Sci. 2010; 56(5):1524-34.
PMID: 21046243
DOI: 10.1007/s10620-010-1447-3.
The effect of a probiotic on hepatic steatosis.
Solga S, Buckley G, Clark J, Horska A, Diehl A
J Clin Gastroenterol. 2008; 42(10):1117-9.
PMID: 18936646
PMC: 4539951.
DOI: 10.1097/MCG.0b013e31816d920c.
Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model.
Fan J, Xu Z, Wang G
World J Gastroenterol. 2005; 11(32):5053-6.
PMID: 16124065
PMC: 4321929.
DOI: 10.3748/wjg.v11.i32.5053.
Increased orocecal transit time in patients with nonalcoholic fatty liver disease.
Soza A, Riquelme A, Gonzalez R, Alvarez M, Perez-Ayuso R, Glasinovic J
Dig Dis Sci. 2005; 50(6):1136-40.
PMID: 15986870
DOI: 10.1007/s10620-005-2720-8.
Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats.
Prieto I, Jimenez F, Aller M, Nava M, Vara E, Garcia C
World J Surg. 2005; 29(7):903-8.
PMID: 15951934
DOI: 10.1007/s00268-005-7757-5.
Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.
Chitturi S, George J
Curr Gastroenterol Rep. 2003; 5(1):18-25.
PMID: 12530944
DOI: 10.1007/s11894-003-0005-y.
Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?.
Evans C, Oien K, MacSween R, Mills P
J Clin Pathol. 2002; 55(9):689-92.
PMID: 12195000
PMC: 1769755.
DOI: 10.1136/jcp.55.9.689.
